Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
Following the first reports of coronavirus disease-19 (COVID-19) by China to the World Health Organization (WHO) on 31st December 2019, more than 4,302,774 novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) cases have been reported by authorities in 212 countries and territories by 1...
Main Authors: | Roshan J. D'Cruz, Arthur W. Currier, Valerie B. Sampson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.00468/full |
Similar Items
-
Convalescent plasma as a therapeutic agent for SARS-CoV, MERS-CoV and SARS-CoV-2: A scoping review
by: Abeba Haile Mariamenatu, et al.
Published: (2021-01-01) -
Evaluation of the performance of a multiplex reverse transcription polymerase chain reaction kit as a potential diagnostic and surveillance kit for rotavirus in Kenya
by: Cliff Odhiambo Philip, et al.
Published: (2019-07-01) -
Anti–SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study
by: Evangelos Terpos, et al.
Published: (2020-11-01) -
Convalescent plasma therapy in patients with coronavirus disease-19 – One year after: A brief review
by: Mariela Irabien-Zúñiga, et al.
Published: (2021-01-01) -
Review of Latest Potential Treatment Modalities in SARS-CoV-2
by: Pratyush Kumar, et al.
Published: (2021-03-01)